Marquardt, A., & Nawroth, P. P. (2017). Farnesoid X receptor agonism protects against diabetic tubulopathy: Potential Add-On Therapy for diabetic nephropathy. Journal of the American Society of Nephrology, 28(11), . https://doi.org/10.1681/ASN.2016101123
Chicago-Zitierstil (17. Ausg.)Marquardt, Andi, und Peter Paul Nawroth. "Farnesoid X Receptor Agonism Protects Against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy." Journal of the American Society of Nephrology 28, no. 11 (2017). https://doi.org/10.1681/ASN.2016101123.
MLA-Zitierstil (9. Ausg.)Marquardt, Andi, und Peter Paul Nawroth. "Farnesoid X Receptor Agonism Protects Against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy." Journal of the American Society of Nephrology, vol. 28, no. 11, 2017, https://doi.org/10.1681/ASN.2016101123.